Cure PharmaceuticalCure Pharmaceutical (OTC:CURR) announced today that it received confirmation of a patent for its Curefilm Blue platform.\

The U.S. Patent Office (USPTO) provided notification to Cure that U.S. Patent No. 11,179,331 (the ’331 patent) is set to issue on November 23, 2021. The ‘331 patent (“Oral Soluble Film Containing Sildenafil Citrate”) covers Curefilm blue.

Get the full story at our sister site, Drug Delivery Business News.